The online licensing system will be unavailable Thursday, May 28, 2026 from 10:00 PM to 10:30 PM CT due to scheduled maintenance for SnapPay.

  • You will not be able to submit applications, renew licenses, or make payments during this time.
  • You are strongly encouraged to complete your renewal in advance of the outage to avoid any interruption in licensure status.

TEXAS STATE BOARD OF PHARMACY

FDA Emergency Use Authorization for Paxlovid

The U.S. Food and Drug Administration (FDA) revised the Emergency Use Authorization (EUA) for Paxlovid to authorize state-licensed pharmacists to prescribe Paxlovid to eligible patients under certain conditions.

For more information and conditions that would not allow a pharmacist to prescribe Paxlovid, read the FDA's press release regarding the EUA.

You can also find the press release, EUA letter of authorization, FDA's compilation of frequently asked questions on the EUA, and a fact sheet for healthcare providers via the buttons below.